New cancer treatment cash boost for NHS
Cancer charities have welcomed a cash boost to services that will prevent the need for patients to travel to England for specialist treatment.
Health Minister Simon Hamilton said funding has been earmarked to invest in stereotactic ablative radiotherapy (SABR).
Clinicians use SABR to treat small, well defined tumours that are deep within the body by directing beams from more angles than other types of radiotherapy.
This offers the potential for better cure rates and improved sparing of normal organs. Patients previously had to travel to England for this treatment.
The minister said: "This additional resource will allow us to build expertise and capacity across the range of highly specialist professionals required to deliver this therapy to high standards and safely.
"The recent publication of cancer incidence and survival rates shows that we are making good progress in tackling cancer. I want to see this continue and this latest development is further evidence of my commitment to that."